RepliCel Life Sciences Inc (REPCF)
0.0428
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
RepliCel Life Sciences Total Assets (Quarterly): 0.2439M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.2439M |
| June 30, 2023 | 0.374M |
| March 31, 2023 | 0.8017M |
| December 31, 2022 | 0.5881M |
| September 30, 2022 | 0.3339M |
| June 30, 2022 | 0.4462M |
| March 31, 2022 | 0.3777M |
| December 31, 2021 | 0.4641M |
| September 30, 2021 | 0.5217M |
| June 30, 2021 | 0.5281M |
| March 31, 2021 | 0.6994M |
| December 31, 2020 | 0.3301M |
| September 30, 2020 | 0.2931M |
| June 30, 2020 | 0.3096M |
| March 31, 2020 | 0.1893M |
| December 31, 2019 | 0.387M |
| September 30, 2019 | 0.6102M |
| June 30, 2019 | 0.6537M |
| March 31, 2019 | 1.394M |
| December 31, 2018 | 2.440M |
| September 30, 2018 | 0.0906M |
| June 30, 2018 | 0.1907M |
| March 31, 2018 | 0.34M |
| December 31, 2017 | 0.6728M |
| September 30, 2017 | 0.3634M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.8047M |
| March 31, 2017 | 2.626M |
| December 31, 2016 | 1.356M |
| September 30, 2016 | 0.1441M |
| June 30, 2016 | 0.2532M |
| March 31, 2016 | 0.5012M |
| December 31, 2015 | 0.2997M |
| September 30, 2015 | 0.5633M |
| June 30, 2015 | 1.602M |
| March 31, 2015 | 0.9344M |
| December 31, 2014 | 1.845M |
| September 30, 2014 | 3.046M |
| June 30, 2014 | 4.170M |
| March 31, 2014 | 1.333M |
| December 31, 2013 | 1.928M |
| September 30, 2013 | 3.167M |
| June 30, 2013 | 0.2085M |
| March 31, 2013 | 0.6702M |
| December 31, 2012 | 0.5081M |
| September 30, 2012 | 1.102M |
| June 30, 2012 | 1.624M |
| March 31, 2012 | 1.702M |
| December 31, 2011 | 0.6185M |
| September 30, 2011 | 1.243M |
| June 30, 2011 | 2.089M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.1893M
Minimum
Mar 2020
0.8017M
Maximum
Mar 2023
0.4529M
Average
0.4166M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| InMed Pharmaceuticals Inc | 13.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.127M |
| Shareholders Equity (Quarterly) | -4.883M |
| Debt to Equity Ratio | -0.0062 |
| Current Ratio | 0.1298 |
| Net Debt Paydown Yield | -0.00% |